BioCentury
ARTICLE | Company News

Acton, Forest Laboratories sales and marketing update

January 11, 2010 8:00 AM UTC

Acton received exclusive, worldwide rights to develop and commercialize Forest's Aerospan flunisolide. Forest will receive an undisclosed upfront payment and is eligible for milestones and royalties. ...